A carregar...
Treatment of Chronic Myelomonocytic Leukemia with 5-Azacytidine: Case Reports
Epigenetic therapy with hypomethylating agent (5-azacytidine; AZA) is common in the management of specific subtypes of myelodysplastic syndrome (MDS), but there are only few studies in chronic myelomonocytic leukemia (CMML) patients. In this paper our experience with 3 CMML patients treated with AZA...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi Publishing Corporation
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3420792/ https://ncbi.nlm.nih.gov/pubmed/22937326 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/369086 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|